Authors:
SAWAMOTO Y
PRESCOTT R
ZHONG DG
SAENKO EL
MAUSERBUNSCHOTEN E
PEERLINCK K
VANDENBERG M
SCANDELLA D
Citation: Y. Sawamoto et al., DOMINANT C2 DOMAIN EPITOPE SPECIFICITY OF INHIBITOR ANTIBODIES ELICITED BY A HEAT PASTEURIZED PRODUCT, FACTOR-VIII CPS-P, IN PREVIOUSLY TREATED HEMOPHILIA-A PATIENTS WITHOUT INHIBITORS, Thrombosis and haemostasis, 79(1), 1998, pp. 62-68
Authors:
SAENKO EL
SCANDELLA D
YAKHYAEV AV
GRECO NJ
Citation: El. Saenko et al., ACTIVATION OF FACTOR-VIII BY THROMBIN INCREASES ITS AFFINITY FOR BINDING TO SYNTHETIC PHOSPHOLIPID-MEMBRANES AND ACTIVATED PLATELETS, The Journal of biological chemistry, 273(43), 1998, pp. 27918-27926
Citation: El. Saenko et D. Scandella, THE ROLE OF THE ACIDIC REGION OF THE FACTOR-VIII LIGHT-CHAIN IN ITS BINDING TO VONWILLEBRAND FACTOR, Thrombosis and haemostasis, 1997, pp. 2334-2334
Citation: El. Saenko et D. Scandella, THE ACIDIC REGION OF THE FACTOR-VIII LIGHT-CHAIN AND THE C2 DOMAIN TOGETHER FORM THE HIGH-AFFINITY BINDING-SITE FOR VON-WILLEBRAND-FACTOR, The Journal of biological chemistry, 272(29), 1997, pp. 18007-18014
Authors:
THOMPSON AR
MURPHY MEP
LIU ML
SAENKO EL
HEALEY JF
LOLLAR P
SCANDELLA D
Citation: Ar. Thompson et al., LOSS OF TOLERANCE TO EXOGENOUS AND ENDOGENOUS FACTOR-VIII IN A MILD HEMOPHILIA-A PATIENT WITH AN ARG(593) TO CYS MUTATION, Blood, 90(5), 1997, pp. 1902-1910
Authors:
PRESCOTT R
NAKAI H
SAENKO EL
SCHARRER I
NILSSON IM
HUMPHRIES JE
HURST D
BRAY G
SCANDELLA D
Citation: R. Prescott et al., THE INHIBITOR ANTIBODY-RESPONSE IS MORE COMPLEX IN HEMOPHILIA-A PATIENTS THAN IN MOST NONHEMOPHILIACS WITH FACTOR-VIII AUTOANTIBODIES, Blood, 89(10), 1997, pp. 3663-3671
Citation: El. Saenko et al., SLOWED RELEASE OF THROMBIN-CLEAVED FACTOR-VIII FROM VON-WILLEBRAND-FACTOR BY A MONOCLONAL AND A HUMAN-ANTIBODY IS A NOVEL MECHANISM FOR FACTOR-VIII INHIBITION, The Journal of biological chemistry, 271(44), 1996, pp. 27424-27431
Citation: El. Saenko et D. Scandella, THE ACIDIC REGION OF THE FACTOR-VIII LIGHT-CHAIN AND THE C2 DOMAIN TOGETHER FORM A HIGH-AFFINITY BINDING-SITE FOR VON-WILLEBRAND-FACTOR, Blood, 88(10), 1996, pp. 1287-1287
Citation: El. Saenko et D. Scandella, MECHANISM FOR INHIBITION OF FACTOR-VIII BINDING TO PHOSPHOLIPID BY VON-WILLEBRAND-FACTOR, Thrombosis and haemostasis, 73(6), 1995, pp. 1215-1215
Authors:
HEALEY JF
LUBIN IM
NAKAI H
SAENKO EL
HOYER LW
SCANDELLA D
LOLLAR P
Citation: Jf. Healey et al., RESIDUES 484-508 CONTAIN A MAJOR DETERMINANT OF THE INHIBITORY EPITOPE IN THE A2 DOMAIN OF HUMAN FACTOR-VIII, The Journal of biological chemistry, 270(24), 1995, pp. 14505-14509
Citation: El. Saenko et D. Scandella, A MECHANISM FOR INHIBITION OF FACTOR-VIII BINDING TO PHOSPHOLIPID BY VON-WILLEBRAND-FACTOR, The Journal of biological chemistry, 270(23), 1995, pp. 13826-13833
Citation: El. Saenko et al., A NOVEL MECHANISM FOR INHIBITION OF FACTOR-VIII ACTIVIN BY AN ANTIBODY WITH A C2 DOMAIN EPITOPE, RESIDUES 2248-2185, Blood, 86(10), 1995, pp. 749-749
Citation: El. Saenko et al., BIOLOGICAL FUNCTIONS OF CERULOPLASMIN EXPRESSED THROUGH COPPER-BINDING SITES AND A CELLULAR RECEPTOR, The Journal of trace elements in experimental medicine, 7(2), 1994, pp. 69-88
Authors:
SAENKO EL
SKOROBOGATKO OV
TARASENKO P
ROMASHKO V
ZHURAVETZ L
ZADOROZHNAYA L
SENJUK OF
YAROPOLOV AI
Citation: El. Saenko et al., MODULATORY EFFECTS OF CERULOPLASMIN ON LYMPHOCYTES, NEUTROPHILS AND MONOCYTES OF PATIENTS WITH ALTERED IMMUNE STATUS, Immunological investigations, 23(2), 1994, pp. 99-114
Authors:
SAENKO EL
SHIMA M
RAJALAKSHMI KJ
SCANDELLA D
Citation: El. Saenko et al., A ROLE FOR THE C2 DOMAIN OF FACTOR-VIII IN BINDING TO VON-WILLEBRAND-FACTOR, The Journal of biological chemistry, 269(15), 1994, pp. 11601-11605
Citation: El. Saenko et D. Scandella, A FRAGMENT CONTAINING RESIDUES 1-272 OF MATURE VON-WILLEBRAND-FACTOR BINDS TO THE C2 DOMAIN OF FACTOR-VIII, Circulation, 90(4), 1994, pp. 618-618
Citation: El. Saenko et D. Scandella, A FRAGMENT CONTAINING RESIDUES 1-272 OF MATURE VON-WILLEBRAND-FACTOR BINDS TO THE C2 DOMAIN OF FACTOR-VIII, Circulation, 90(4), 1994, pp. 618-618